Michael Marquardt is an entrepreneur, chief executive, and board-level advisor whose career sits at the intersection of geopolitics, corporate governance, security, digital risk, and advanced technology.

Born and raised in Cold War Berlin, Mr. Marquardt developed an early and enduring interest in how political systems, security dynamics, and institutional design shape economic and corporate outcomes — a perspective that has informed his professional work for more than three decades across Europe, Asia, and the United States.

Over the course of his career, Mr. Marquardt has lived, worked, and served on boards and advisory bodies across Europe and Southeast Asia for many years, engaging directly with the region’s political economies, regulatory systems, state-business relationships, and geopolitical dynamics. That experience — spanning emerging markets, family-controlled enterprises, multinational corporations, and public-private partnerships — has shaped his approach to risk, governance, and institutional credibility in complex and fast-changing environments.

He is currently the Chief Executive Officer of Epi One, a biotechnology company focused on early cancer detection, where he works closely with boards, regulators, investors, and scientific leaders on issues ranging from governance and regulatory strategy to capital formation, data governance, and cross-border collaboration. His work regularly engages questions of national regulation, information integrity, public trust in science and institutions, and the political economy of healthcare and innovation.

Earlier in his career, Mr. Marquardt led and advised organizations in the areas of information technology, medical and healthcare services, and corporate security — including serving in senior leadership at a global risk management firm founded by former FBI Director Louis Freeh. In those roles, he advised boards and senior executives on crisis response, reputational risk, regulatory exposure, geopolitical developments, and the growing convergence of physical, digital, and informational risk.

Mr. Marquardt has served on and chaired numerous boards and advisory bodies. He is a former Chair of the national Board of Directors of the American Cancer Society and currently serves on its Audit Committee and its Governance & Nominating Committee, with responsibility for oversight of financial integrity, enterprise risk, leadership succession, and institutional trust. His board work has consistently focused on how organizations maintain legitimacy, credibility, and stakeholder confidence in periods of uncertainty, polarization, and rapid change.

He is a frequent speaker and writer on corporate governance, risk, and leadership, including for the National Association of Corporate Directors (NACD), where he is an NACD.DC (Director Certified), a Board Leadership Fellow, holds NACD’s Cybersecurity Oversight Certification, and served as a Commissioner on the Future of the American Board. His work emphasizes how boards can better integrate geopolitical risk, cyber and information risk, regulatory uncertainty, and stakeholder trust into their oversight and decision-making frameworks.

Mr. Marquardt holds a B.S. in Medical Biology and an M.A. in Analytical Biochemistry, and is bilingual in German and English. In January of 2022, President Biden appointed him to serve on the U.S. Commission for the Preservation of America’s Heritage Abroad.